Takeda Exercises Option to Acquire Adaptate Biotherapeutics

By Sasha Yachu

Pharma Deals Review: Vol 2022 Issue 1 (Table of Contents)

Published: 29 Jan-2022

DOI: 10.3833/pdr.v2022.i1.2666     ISSN: 1756-7874

Section: Mergers & Acquisitions



In a move to bolster its immuno-oncology portfolio, Takeda Pharmaceutical has exercised its option to acquire Adaptate Biotherapeutics for an undisclosed amount...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details